Virion Therapeutics Company
Virion Therapeutics is a science-driven company developing innovative immune-based treatments for virally-associated cancers.
Investors
Estimated Revenue:
Less than $1M
Funding Status:
Early Stage Venture
Industry:
Viral Vectors
Investors Number:
7
Last Funding Date:
2020-08-24
Founded Date:
2018-01-01
Headquarters:
Newark, Delaware, United States
Total Funding:
14075858
Last Funding Type:
Debt Financing